You know the economy is having a tough time of it if Johnson & Johnson (NYSE:JNJ) is feeling its effects. This may come as a surprise to many investors who are quick to assume that no company is being spared from the recession.

IN PICTURES: Learn To Invest In 10 Steps

While it looks like Johnson & Johnson may have a slower year in 2009, what will surprise most investors about Johnson & Johnson is the exact opposite. Every investor worth his salt should hold this company in high regard.
Numbers Don't Lie
While it appears that Johnson & Johnson will experience a sales decline in 2009, it will be the first for the company in 76 years. If profits decline, that will be the first such decline in 25 years. This is an unbelievable track record, and one that unequivocally proves that JNJ can weather the worst of economic storms.

Johnson & Johnson also has an compounded annual growth rate of 10.1 percent over the past 100 years. And at the time, the company was already 23 years old. Even "younger" companies like Procter and Gamble (NYSE:PG), Kraft (NYSE:KFT), and Kellogg's (NYSE:K), all of which sell a wide array of consumer staples, can't touch this record. It's simply phenomenal, and is one of the most overlooked facts in business to the masses. (For more, see A Guide To Consumer Staples.)

Follow the Smart Money
However, many of best investors are well aware of the company's outstanding performance. Warren Buffett's Berkshire Hathaway (NYSE: BRK.A, BRK-B) owns it. The "Buffett of Canada," Prem Watsa at Fairfax Financial (NYSE:FFH) owns a lot of it.

So, what have all these extraordinary numbers meant? For one, JNJ easily outperformed the market in 2008. But one year doesn't mean much. This does: a single share bought in 1944 at $37.50, when the company went public, assuming reinvested dividends, the value today would be approximately $900,000, an annual compound return of 17% over 64 years.

It's not Over
While the future returns of JNJ simply can not match the last six decades of performance, the company is in a very sweet spot today because its products have unlimited growth potential. JNJ is just now really penetrating China and India, and with products like Tylenol, Band-Aids, and baby shampoo, the opportunities are endless. And with a dividend yield of 3.5% and a payout that's as assured as anything in business, the company can easily reward investors.

Simple, but Not Easy
Warren Buffett has often remarked that investing is "simple, but not easy." It's simple in that you only need to find a few great companies to do well over time. It's not easy because many want to get rich quick. Find great businesses like JNJ, and you will do exceedingly well over time. (For more, see Riding The Bear Market Into A Bull Market.)

Related Articles
  1. Investing

    The ABCs of Bond ETF Distributions

    How do bond exchange traded fund (ETF) distributions work? It’s a question I get a lot. First, let’s explain what we mean by distributions.
  2. Mutual Funds & ETFs

    4 Mutual Funds Warren Buffet Would Buy

    Learn about four mutual funds Warren Buffett would invest and recommend to his trustee, and discover detailed analysis of these mutual funds.
  3. Stock Analysis

    Markets Are Tanking: Time to Buy Like Buffett

    Learn about three value stocks Warren Buffett holds in his portfolio. See how Buffett uses market declines to find good deals on stocks.
  4. Stock Analysis

    3 Stocks that Are Top Bets for Retirement

    These three stocks are resilient, fundamentally sound and also pay generous dividends.
  5. Investing News

    Are Stocks Cheap Now? Nope. And Here's Why

    Are stocks cheap right now? Be wary of those who are telling you what you want to hear. Here's why.
  6. Investing News

    4 Value Stocks Worth Your Immediate Attention

    Here are four stocks that offer good value and will likely outperform the majority of stocks throughout the broader market over the next several years.
  7. Investing News

    These 3 High-Quality Stocks Are Dividend Royalty

    Here are three resilient, dividend-paying companies that may mitigate some worry in an uncertain investing environment.
  8. Stock Analysis

    An Auto Stock Alternative to Ford and GM

    If you're not sure where Ford and General Motors are going, you might want to look at this auto investment option instead.
  9. Mutual Funds & ETFs

    The 4 Best Buy-and-Hold ETFs

    Explore detailed analyses of the top buy-and-hold exchange traded funds, and learn about their characteristics, statistics and suitability.
  10. Investing

    Procter & Gamble Restructures, Sheds 100 Brands

    All businesses face adversity, and Procter & Gamble is no exception. We take a look at recent developments affecting this global giant.
  1. What are the risks of annuities in a recession?

    Annuities come in several forms, the two most common being fixed annuities and variable annuities. During a recession, variable ... Read Full Answer >>
  2. How do dividends affect retained earnings?

    When a company issues a cash dividend to its shareholders, the retained earnings listed on the balance sheet are reduced ... Read Full Answer >>
  3. What is the difference between called-up share capital and paid-up share capital?

    The difference between called-up share capital and paid-up share capital is investors have already paid in full for paid-up ... Read Full Answer >>
  4. Why would a corporation issue convertible bonds?

    A convertible bond represents a hybrid security that has bond and equity features; this type of bond allows the conversion ... Read Full Answer >>
  5. What types of capital are not considered share capital?

    The money a business uses to fund operations or growth is called capital, and there are a number of capital sources available. ... Read Full Answer >>
  6. How does additional paid in capital affect retained earnings?

    Both additional paid-in capital and retained earnings are entries under the shareholders' equity section of a company's balance ... Read Full Answer >>

You May Also Like

Trading Center
You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!